Disclosure Panels Details Page
Bladder/Penile Cancers Panel - Disclosures as of 12/21/2022
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Michael Abern MD | Medtronic, Inc. Veru Incorporated |
None | None | None | - |
| Neeraj Agarwal MD | None | Daiichi- Sankyo Co. Exelixis Inc. Merck & Co., Inc. Pfizer Inc. |
None | None | - |
| Rick Bangs MBA, PMP | None | Nonagen | Nonagen | Nonagen | - |
| Marian Birkeland PhD | None | None | None | None | - |
| Mark Buyyounouski MD, MS, FASTRO | None | None | None | None | - |
| Carly Cassara MSc | None | None | None | None | - |
| Kevin Chan MD | None | None | None | None | - |
| Sam Chang MD, MBA | ImmunityBio Inc Merck & Co., Inc. mIR photocure inc. Prokarium Tu Therapeutics urogen inc |
CGOncology Expert witness testimony Janssen Pharmaceutica Products, LP Merck & Co., Inc. mIR Pacific Edge photocure Prokarium Tu Therapeutics Urogen |
None | None | - |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Thomas Flaig MD | Agensys, Inc. Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Genentech, Inc. Janssen Pharmaceutica Products, LP Merck & Co., Inc. sanofi-aventis U.S. Seattle Genetics, Inc. |
Aurora Oncology Janssen Pharmaceutica Products, LP Seattle Genetics, Inc. |
None | Aurora Oncology |The University of Colorado was issued patents for work I did as a university employee in my laboratory - two patents have now been issued for this work and licensed to Aurora Oncology. There are no commercial products related to this work. | - |
| Terence Friedlander MD | AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Genentech, Inc. Incyte Corporation Janssen Pharmaceutica Products, LP Seattle Genetics, Inc. Tizona/Trishula Pharmaceuticals |
Basilea Pharmaceuticals Legal case about failure to diagnose testicular cancer. Unrelated to medical trials or research. Serving as a consultant/expert witness. Taiho Pharmaceuticals Co., Ltd. |
AbbVie, Inc. Astellas Pharma US, Inc. EMD Serono |
None | - |
| Richard Greenberg MD, FACS | None | None | None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Lisa Gurski PhD | None | None | None | None | - |
| Khurshid Guru MD | None | None | None | None | - |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Harry Herr MD | None | None | None | None | - |
| Jean Hoffman-Censits MD | Genentech, Inc. Ikena Seattle Genetics, Inc. |
Seattle Genetics, Inc. | None | None | - |
| Hristos Kaimakliotis MD | None | None | None | None | - |
| Amar Kishan MD | ViewRay, Inc. | Varian Medical Systems, Inc. | ViewRay, Inc. | None | - |
| Shilajit Kundu MD | None | None | None | None | - |
| Subodh Lele MD | None | None | None | None | - |
| Ronac Mamtani MD, MSCE | Astellas Pharma US, Inc. Bristol Myers Squibb Merck & Co., Inc. |
Aaronson Rappaport Feinstein & Deutsch, LLP Aptitude Health Astellas Pharma US, Inc. Bristol Myers Squibb Curio Science The Perry Law Firm, LLC |
Flatiron Health, Inc. | None | - |
| Vitaly Margulis MD | None | None | None | None | - |
| Omar Mian MD, PhD | None | Bayer HealthCare | None | None | - |
| Jeff Michalski MD, MBA | None | None | None | None | - |
| Jeffrey Montgomery MD, MHSA | None | Ambu | None | None | - |
| Mamta Parikh MD, MS | Karyopharm Therapeutics | AstraZeneca Pharmaceuticals LP Exelixis Inc. Oncocyte |
None | None | - |
| Anthony Patterson MD | None | None | None | None | - |
| Charles Peyton MD | None | None | None | None | - |
| Elizabeth Plimack MD, MS | Astellas Pharma US, Inc. Bristol Myers Squibb Genentech, Inc. Merck & Co., Inc. |
Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Bristol Myers Squibb EMD Serono Exelixis Inc. IMV Merck & Co., Inc. Natera Pfizer Inc. Seattle Genetics, Inc. |
None | None | - |
| Kamal Pohar MD | None | Photocure | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Mark Preston MD, MPH | Merck & Co., Inc. | Bayer HealthCare | None | None | - |
| Kyle Richards MD, FACS | None | None | None | None | - |
| Wade Sexton MD | None | Pacific Edge UroGen |
None | None | - |
| Arlene Siefker-Radtke MD | Basilea Bristol Myers Squibb Gilead Sciences, Inc. Janssen Pharmaceutica Products, LP Merck & Co., Inc. Nektar Therapeutics |
AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Eli Lilly and Company G1 Therapeutics Genentech, Inc. Gilead Sciences, Inc. Ideeya Immunomedics, Inc. Janssen Pharmaceutica Products, LP Loxo Merck & Co., Inc. Mirati Therapeutics Nektar Therapeutics Seattle Genetics, Inc. Taiho Pharmaceuticals Co., Ltd. |
None | None | - |
| Philippe Spiess MD, MS, FACS, FRCS | None | None | None | None | - |
| Tyler Stewart MD | None | Astellas Pharma US, Inc. SeaGen |
None | GRAIL | - |
| Bettyanne Sunderland BSN, OCN | None | None | None | None | - |
| Matthew Tollefson MD | None | None | None | None | - |
| Jonathan Tward MD, PhD | Bayer HealthCare Myriad Genetic Laboratories, Inc. |
Boston Scientific Corporation Myriad Genetic Laboratories, Inc. |
None | None | - |
| Jonathan Wright MD, MS, FACS | Altor Biosciences Bristol Myers Squibb Janssen Pharmaceutica Products, LP Merck & Co., Inc. Pacific Edge Veracyte |
None | None | UpToDate | - |